Therapeutics: ADP-ribosylation factor 6 (ARF6); G protein q polypeptide (GNAQ; G-ALPHA-q)

Cancer

INDICATION: Melanoma

Cell culture and mouse studies suggest inhibiting ARF6 could help treat GNAQ-mutant uveal

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE